Introducing the
Opticyte VitalO₂

Delivering Definitive Data When It Matters Most

Early Detection of Low Cellular Oxygen for Better Patient Outcomes

The sooner clinicians detect low oxygen levels in a patient’s cells, the quicker they can intervene to prevent organ failure and save lives. The Opticyte VitalO₂ is the industry’s first and only device that can detect low cellular oxygen levels, known as hypoxia, in real-time. The Opticyte VitalO₂ provides immediate, definitive data to diagnose, treat and track patient response.

Opticyte Render

This breakthrough noninvasive technology not only provides clinicians with the ability to detect oxygen deficiency in organs quickly for earlier intervention, it also enables clinicians to continuously monitor cellular oxygen levels throughout patient treatment, such as during a blood transfusion or surgery. The Opticyte VitalO₂ allows for an unprecedented view into a patient’s current cellular metabolism, so clinicians can determine when a patient’s cellular oxygen levels are restored to normal levels.

A Beacon to Prevent Organ Failure

See Indications of Sepsis Earlier and With Greater Accuracy

Patients with sepsis and other severe conditions often present normal arterial blood oxygen levels even when insufficient oxygen is getting to tissues, which can quickly result in organ failure and death.

Pulse oximeters, a decades-old technology, only measure oxygen saturation in arterial blood, not in cells or organs where the indication of sepsis, hemorrhage, and cardiac failure is first presented. When a patient is suffering from these potentially fatal conditions, pulse oximeters may display normal oxygen readings and fail to detect a problem. Delays in recognizing oxygen deficiency narrow the window of opportunity to prevent organ damage.

The Opticyte VitalO₂’s advanced algorithm and tailored optical spectroscopy technology provide the only direct measure of fluctuating oxygen levels inside cells, computationally separating cell oxygenation signals from blood oxygenation signals. Continuous monitoring of cellular oxygen levels will allow clinicians to directly and immediately evaluate the severity of oxygen deficiency and more confidently assess the proper timing and doses for interventions such as blood transfusions, fluid boluses, or vasopressors.

Zoom to Cell Level

Shining Light on the Next Standard of Care

Proprietary Technologies for Real-Time Insights

The Opticyte VitalO₂ shines light in the visible and near-infrared spectrum (500-800 nm) through the skin on the patient’s palm and measures the reflected light. Opticyte’s proprietary pattern-matching algorithm analyzes the optical spectra to produce real-time cellular oxygenation measurements from the patient’s muscle tissue. When there is systemic oxygen deficiency, cells in muscle and core organs like the brain, heart, lungs, kidneys, and liver are deprived of oxygen. Therefore, low oxygen levels in muscle are correlated with low oxygen levels in critical organs and eventual organ failure.

Join the Opticyte Solution

Learn How